Page last updated: 2024-11-05

chromium sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chromium(III) sulfate : A compound of chromium and sulfate in which the ratio of chromium (in the +3 oxidation state) to sulfate is 2:3 [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24930
CHEBI ID53471
MeSH IDM0121484

Synonyms (61)

Synonym
c.i. 77305
chromic sulfate
chromium iii sulfate
dichromium trisulfate
dichromium sulfate
chromium sulfate (cr2(so4)3)
chromium sulfate
chromium(iii) sulfate (2:3)
nsc-51151
chromium sulfate (2:3)
chromic sulfate (cr2(so4)3)
10101-53-8
einecs 233-253-2
chromitan b
chromium(iii) sulfate
nsc 51151
dichromium trisulphate
chromitan na
cromitan b
chromium sulphate
dichromium sulphate
chromitan ms
baychrom a
chromic sulphate
ccris 6182
baychrom f
dichromium tris(sulphate)
chromium sulphate (2:3)
koreon
chromium (iii) sulfate (2:3)
ci 77305
chromium sulfate (van)
hsdb 2543
chronisulfat [german]
chromosulfuric acid [un2240] [corrosive]
sulfuric acid, chromium salt
chromosulfuric acid
un2240
chromium(3+) trisulfate
FT-0658527
CHEBI:53471 ,
A800314
chromium (iii) sulfate
y0c99n5tmz ,
unii-y0c99n5tmz
chronisulfat
14489-25-9
chromium(iii) sulphate
chromium(iii) sulfate [hsdb]
chromium iii sulphate
chromic sulfate [vandf]
chromic sulfate [mi]
AKOS015897499
GRWVQDDAKZFPFI-UHFFFAOYSA-H
sulfuric acid chromium(3+)salt(3:2),pentadecahydrate
chromisulfat
chromium sulfate solution
DTXSID20890642
chromium(3+);trisulfate
dichromium tris(sulfate)
chromium(3+) sulfate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" General toxic effects, only observed with high-exposure levels of basic chromium sulfate, included sporadic signs of labored breathing and depressed body weights."( Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate.
Derelanko, MJ; Hilaski, RJ; Löser, E; Rinehart, WE; Thompson, RB, 1999
)
0.74
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
metal sulfateSulfate salts where the cation is a metal ion.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (21.21)18.7374
1990's7 (21.21)18.2507
2000's6 (18.18)29.6817
2010's11 (33.33)24.3611
2020's2 (6.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 65.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index65.32 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index108.03 (26.88)
Search Engine Supply Index2.04 (0.95)

This Compound (65.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies5 (13.89%)4.05%
Observational0 (0.00%)0.25%
Other30 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]